Greenyn Biotechnology Co., Ltd (6846.TWO)
TWD 77.8
(0.0%)
TWD 77.8
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 192.4 Million TWD | -8.55% |
| 2022 | 210.39 Million TWD | 8.64% |
| 2021 | 193.67 Million TWD | 3.27% |
| 2020 | 187.54 Million TWD | 44.6% |
| 2019 | 160.68 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 38.08 Million TWD | -37.88% |
| 2024 Q1 | 61.31 Million TWD | 12.24% |
| 2023 Q4 | 54.62 Million TWD | 22.81% |
| 2023 FY | - TWD | -8.55% |
| 2023 Q3 | 44.48 Million TWD | -5.41% |
| 2023 Q2 | 47.02 Million TWD | 1.65% |
| 2023 Q1 | 46.26 Million TWD | -3.74% |
| 2022 FY | - TWD | 8.64% |
| 2022 Q4 | 48.05 Million TWD | 0.0% |
| 2021 FY | - TWD | 3.27% |
| 2020 FY | - TWD | 44.6% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 408.628% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 285.689% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 340.286% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 231.809% |
| NaviFUS Corp. | -55.79 Million TWD | 444.837% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | -92.716% |
| TaiRx, Inc. | -208.64 Million TWD | 192.215% |
| Sinew Pharma Inc. | -163.63 Million TWD | 217.583% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 117.958% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 11176.684% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 184.879% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 516.058% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 51.118% |
| AP Biosciences Inc | -325.51 Million TWD | 159.107% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 79.455% |
| RBC Bioscience Corporation | 36.54 Million TWD | -426.451% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 55.622% |
| EirGenix Inc. | -664.4 Million TWD | 128.958% |
| Enimmune corporation | -228.96 Million TWD | 184.032% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 831.567% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 128.192% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 636.746% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 862.501% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 156.675% |
| TCI GENE Inc. | 25.98 Million TWD | -640.549% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 1185.423% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 128.537% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 528.026% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | -452.276% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 366.799% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 219.611% |
| Neith Corporation | -33.61 Million TWD | 672.455% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | -178.267% |
| VBI | -6.97 Million TWD | 2859.639% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 70.649% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 233.896% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 682.93% |
| CHO Pharma, Inc. | -277.73 Million TWD | 169.276% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 412.849% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 273.902% |
| Visgeneer Inc. | 973 Thousand TWD | -19674.101% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | -160.34% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 1259.188% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 530.054% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 270.108% |
| GlycoNex Incorporation | -126.82 Million TWD | 251.704% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 118.418% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | -560.494% |
| PharmaEngine, Inc. | 347.3 Million TWD | 44.602% |
| Intech Biopharm Corporation | -219.58 Million TWD | 187.621% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | -782.173% |
| BiOptic Inc. | 65.03 Million TWD | -195.83% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | -11.712% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 167.799% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | -1289.184% |
| OBI Pharma, Inc. | -855.08 Million TWD | 122.501% |
| Savior Lifetec Corporation | 219.6 Million TWD | 12.387% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 450.363% |
| Level Biotechnology Inc. | 98.7 Million TWD | -94.928% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 119.413% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 307.861% |
| Acepodia, Inc. | -764.51 Million TWD | 125.166% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 141.818% |